pentobarbital has been researched along with Bronchitis in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
Bronchitis: Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gold, MI | 1 |
| Reichenberg, S | 1 |
| Freeman, E | 1 |
1 trial available for pentobarbital and Bronchitis
| Article | Year |
|---|---|
Respiratory depression in the sedated bronchitic patient rapid version of the CO2 response curve.
Topics: Bronchitis; Carbon Dioxide; Clinical Trials as Topic; Humans; Pentobarbital; Placebos; Respiration; | 1969 |